Osegawa M, Makino H, Kanatsuka A, Suzuki T, Yoshida S
Metabolism. 1984 Aug;33(8):754-9. doi: 10.1016/0026-0495(84)90218-x.
The effects of dexamethasone administration and adrenalectomy on insulin-sensitive phosphodiesterase were studied in rat fat cells. Isolated fat cells were incubated at 37 degrees C for ten minutes or without insulin. A crude microsomal fraction prepared by differential centrifugation was used for the determination of phosphodiesterase level. With dexamethasone treatment (400 micrograms/kg/day) for seven days, specific activity of the enzyme and its sensitivity (ED50) to insulin were decreased, as was the maximal responsiveness to insulin. Under conditions of adrenalectomy, the specific activity and the sensitivity (ED50) were increased while the maximal responsiveness to insulin was decreased. Following dexamethasone treatment specific insulin binding was decreased, and after adrenalectomy it increased. These findings were attributed to changes in the number of insulin receptors per cell rather than to changes in affinity. Alterations in insulin sensitivity (ED50) of the enzyme seemed to be due to alterations in insulin binding to the receptor. The reduction in maximal insulin responsiveness suggested postreceptor defects in both experimental groups. The mechanism related to alterations in the specific activity was not thoroughly clarified; however, serum insulin levels may specifically affect the enzyme activity.
在大鼠脂肪细胞中研究了地塞米松给药和肾上腺切除术对胰岛素敏感型磷酸二酯酶的影响。分离的脂肪细胞在37℃下孵育10分钟或不添加胰岛素。通过差速离心制备的粗微粒体部分用于测定磷酸二酯酶水平。用地塞米松(400微克/千克/天)治疗7天后,该酶的比活性及其对胰岛素的敏感性(半数有效剂量)降低,对胰岛素的最大反应性也降低。在肾上腺切除的情况下,比活性和敏感性(半数有效剂量)增加,而对胰岛素的最大反应性降低。地塞米松治疗后特异性胰岛素结合减少,肾上腺切除后增加。这些发现归因于每个细胞胰岛素受体数量的变化,而非亲和力的变化。该酶胰岛素敏感性(半数有效剂量)的改变似乎是由于胰岛素与受体结合的改变。最大胰岛素反应性的降低表明两个实验组均存在受体后缺陷。与比活性改变相关的机制尚未完全阐明;然而,血清胰岛素水平可能特异性影响酶活性。